Mechanism of Zhishi Xiebai Guizhi decoction to treat atherosclerosis: Insights into experiments, network pharmacology and molecular docking
Authors:
Open Access
- 15 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 333, 118466
Abstract
No abstract availableKeywords
Funding Information
- Wuxi health commission
- National Natural Science Foundation of China
This publication has 67 references indexed in Scilit:
- Plantamajoside attenuates cardiac fibrosis via inhibiting AGEs activated‐RAGE/autophagy/EndMT pathwayPhytotherapy Research, 2022
- Therapeutic potential of traditional Chinese medicine in atherosclerosis: A reviewPhytotherapy Research, 2022
- Focus on ferroptosis, pyroptosis, apoptosis and autophagy of vascular endothelial cells to the strategic targets for the treatment of atherosclerosisArchives of Biochemistry and Biophysics, 2022
- Which Is Safer, Chinese Medicine or Western Medicine? Comparative Analysis Based on Chinese Spontaneous Reporting DatabaseChinese Journal of Integrative Medicine, 2021
- Therapeutic potential of vitamin D in AGE/RAGE-related cardiovascular diseasesCellular and Molecular Life Sciences, 2019
- Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk FactorsJAMA Neurology, 2019
- Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosisCellular and Molecular Life Sciences, 2018
- Treatment of atherosclerosis by traditional Chinese medicine: Questions and quandariesAtherosclerosis, 2018
- Racial Differences in Prevalence and Risk for Intracranial Atherosclerosis in a US Community-Based PopulationJAMA Cardiology, 2017
- HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosisAutoimmunity Reviews, 2012